Literature DB >> 22012546

Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study.

Cecilia Marini1, Silvia Morbelli, Riccardo Armonino, Giovanni Spinella, Mattia Riondato, Michela Massollo, Francesca Sarocchi, Bianca Pane, Carla Augeri, Luca Abete, Giorgio Ghigliotti, Daniela Palmieri, Francesco Fiz, Giuseppe Cittadini, Ezio Fulcheri, Domenico Palombo, Gianmario Sambuceti.   

Abstract

PURPOSE: Conflicting results have been reported about the clinical value of fluorodeoxyglucose (FDG) imaging in predicting the risk of rupture of abdominal aortic aneurysm (AAA). The present study tests the hypothesis that FDG uptake is low in asymptomatic noninflammatory AAA due to the low cell density in aneurysmal walls.
METHODS: Positron emission tomography (PET)/CT imaging was performed in 12 consecutive candidates for AAA surgical repair and in 12 age- and sex-matched controls. At intervention, aneurysmal walls were cut into three sequential blocks. Block A was frozen to cut three 5-μm slices for incubation with 2-3 MBq of FDG for 5 min. Block C was first incubated with the same tracer solution for the same time and subsequently frozen to cut three 5-μm slices. Autoradiographic images were coregistered with immunohistochemical pictures of cell density, type and DNA synthesis as assessed on block B.
RESULTS: No visible uptake in abdominal aorta occurred in any patient or control subject. Immunohistochemistry documented a severe loss of wall structure, with low numbers of cells. Tracer retention directly correlated with overall cell density and with prevalence of cells synthesizing DNA. The metabolic nature of FDG uptake was confirmed by the selective effect of preliminary freezing that decreased tracer content by 90% in regions with high cell density and only by 34% in cold acellular areas.
CONCLUSION: The loss of tissue structure and the marked decrease in cell density account for the low prevalence of positive findings at FDG PET imaging, at least in asymptomatic patients bearing AAAs whose diameter is close to surgical indication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012546     DOI: 10.1007/s00259-011-1955-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

1.  Comparative study in vivo and in vitro of uniformly 14C-labelled and 125I-labelled recombinant fibroblast growth factor 2.

Authors:  S Colin; F Mascarelli; J C Jeanny; R Vienet; G Bouche; Y Courtois; J Labarre
Journal:  Eur J Biochem       Date:  1997-10-15

2.  99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques.

Authors:  Alessio Annovazzi; Elena Bonanno; Marcello Arca; Calogero D'Alessandria; Antonella Marcoccia; Luigi G Spagnoli; Francesco Violi; Francesco Scopinaro; Giorgio De Toma; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

3.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

Authors:  A E Koch; G K Haines; R J Rizzo; J A Radosevich; R M Pope; P G Robinson; W H Pearce
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

5.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

6.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.

Authors:  A E Koch; S L Kunkel; W H Pearce; M R Shah; D Parikh; H L Evanoff; G K Haines; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

Authors:  David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

8.  Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).

Authors:  C W Kotze; L J Menezes; R Endozo; A M Groves; P J Ell; S W Yusuf
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-02-12       Impact factor: 7.069

Review 9.  Surgery for small asymptomatic abdominal aortic aneurysms.

Authors:  David J Ballard; Giovanni Filardo; Gerry Fowkes; Janet T Powell
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  12 in total

Review 1.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

2.  Imaging Biological Pathways in Abdominal Aortic Aneurysms Using Positron Emission Tomography.

Authors:  Michael Bell; Richa Gandhi; Heba Shawer; Charalampos Tsoumpas; Marc A Bailey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-25       Impact factor: 8.311

Review 3.  Role of molecular imaging with positron emission tomographic in aortic aneurysms.

Authors:  Parmanand Singh; Zaid Almarzooq; Brian Salata; Richard B Devereux
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 4.  Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification.

Authors:  Jakub Toczek; Judith L Meadows; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

5.  18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size.

Authors:  Tara D Barwick; O T A Lyons; N G Mikhaeel; M Waltham; M J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-26       Impact factor: 9.236

6.  Utility of (18) F-FDG and (11)C-PBR28 microPET for the assessment of rat aortic aneurysm inflammation.

Authors:  Sean J English; Jose A Diaz; Xia Shao; David Gordon; Melissa Bevard; Gang Su; Peter K Henke; Virginia E Rogers; Gilbert R Upchurch; Morand Piert
Journal:  EJNMMI Res       Date:  2014-05-10       Impact factor: 3.138

7.  (18)F-FDG PET scanning of abdominal aortic aneurysms and correlation with molecular characteristics: a systematic review.

Authors:  U T Timur; J A van Herwaarden; D Mihajlovic; P De Jong; W Mali; F L Moll
Journal:  EJNMMI Res       Date:  2015-12-23       Impact factor: 3.138

8.  Cross-Sectional Imaging to Evaluate the Risk of Rupture in Abdominal Aortic Aneurysms: Review article based on a dissertation submitted to fulfill the academic grade of doctor in medical sciences (….), entitled: Imaging the mechanisms involved in abdominal aortic aneurysms rupture; a step towards patient-specific risk assessment.

Authors:  Alain Nchimi
Journal:  J Belg Soc Radiol       Date:  2016-11-19       Impact factor: 1.894

Review 9.  Nanoparticle-Assisted Diagnosis and Treatment for Abdominal Aortic Aneurysm.

Authors:  Li Yin; Kaijie Zhang; Yuting Sun; Zhenjie Liu
Journal:  Front Med (Lausanne)       Date:  2021-07-07

10.  Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer.

Authors:  Cecilia Marini; Barbara Salani; Michela Massollo; Adriana Amaro; Alessia Isabella Esposito; Anna Maria Orengo; Selene Capitanio; Laura Emionite; Mattia Riondato; Gianluca Bottoni; Cinzia Massara; Simona Boccardo; Marina Fabbi; Cristina Campi; Silvia Ravera; Giovanna Angelini; Silvia Morbelli; Michele Cilli; Renzo Cordera; Mauro Truini; Davide Maggi; Ulrich Pfeffer; Gianmario Sambuceti
Journal:  Cell Cycle       Date:  2013-11-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.